Regulatory aspects on nanomedicines.
Saved in:
| Title: | Regulatory aspects on nanomedicines. |
|---|---|
| Authors: | Sainz V; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Conniot J; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Matos AI; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Peres C; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Zupancic E; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Moura L; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Silva LC; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Florindo HF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Gaspar RS; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. Electronic address: rgaspar@ff.ulisboa.pt. |
| Source: | Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2015 Dec 18; Vol. 468 (3), pp. 504-10. Date of Electronic Publication: 2015 Aug 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26260323 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Regulatory aspects on nanomedicines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sainz+V%22">Sainz V</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Conniot+J%22">Conniot J</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Matos+AI%22">Matos AI</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Peres+C%22">Peres C</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Zupancic+E%22">Zupancic E</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Moura+L%22">Moura L</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Silva+LC%22">Silva LC</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Florindo+HF%22">Florindo HF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Gaspar+RS%22">Gaspar RS</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. Electronic address: rgaspar@ff.ulisboa.pt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372516%22">Biochemical and biophysical research communications</searchLink> [Biochem Biophys Res Commun] 2015 Dec 18; Vol. 468 (3), pp. 504-10. <i>Date of Electronic Publication: </i>2015 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372516 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1090-2104 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220006291X%22">0006291X </searchLink><i>NLM ISO Abbreviation: </i>Biochem Biophys Res Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26260323 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bbrc.2015.08.023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 504 Titles: – TitleFull: Regulatory aspects on nanomedicines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sainz V – PersonEntity: Name: NameFull: Conniot J – PersonEntity: Name: NameFull: Matos AI – PersonEntity: Name: NameFull: Peres C – PersonEntity: Name: NameFull: Zupancic E – PersonEntity: Name: NameFull: Moura L – PersonEntity: Name: NameFull: Silva LC – PersonEntity: Name: NameFull: Florindo HF – PersonEntity: Name: NameFull: Gaspar RS IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 12 Text: 2015 Dec 18 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1090-2104 Numbering: – Type: volume Value: 468 – Type: issue Value: 3 Titles: – TitleFull: Biochemical and biophysical research communications Type: main |
| ResultId | 1 |
